about
In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytesApplication of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics.Efficacy of trovafloxacin against experimental Staphylococcus aureus endocarditis.Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitisClinical and pharmacokinetic evaluation of parental cefoxitin in infants and children.Pharmacokinetics of nafcillin in infants with low birth weights.Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages.Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.Levofloxacin-ceftriaxone combination attenuates lung inflammation in a mouse model of bacteremic pneumonia caused by multidrug-resistant Streptococcus pneumoniae via inhibition of cytolytic activities of pneumolysin and autolysin.Discovery and development of new antimicrobial agents.Lung bacterial clearance in murine pneumococcal pneumoniaBacterial growth in vivo. An important determinant of the pulmonary clearance of Diplococcus pneumoniae in ratsEvaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.Rapid disk test for determining clindamycin serum levels.Improved oxacillin treatment outcomes in experimental skin and lung infection by a methicillin-resistant Staphylococcus aureus isolate with a vraSR operon deletionPharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model.In vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B Streptococcus strains in mice: comparative study with erythromycin and penicillin GBactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model.Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.Comparative efficacy of nalidixic acid and ampicillin for severe shigellosisDeterminants of lung bacterial clearance in normal miceCorrection for bacterial loss in in vitro dilution modelsPharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution.In vitro evaluation of the determinants of bactericidal activity of ampicillin dosing regimens against Escherichia coliPharmacokinetics of carbenicillin in neonates of normal and low birth weight.Comparative pharmacokinetics of cyclacillin and amoxicillin in infants and children.Penetration of cefoxitin into cerebrospinal fluid of infants and children with bacterial meningitisClinical and pharmacokinetic evaluation of parenteral moxalactam in infants and children.Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis.Pharmacokinetics of cefuroxime in infants and children with bacterial meningitisHigh-pressure liquid chromatographic quantitation of azlocillin.Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection modelComparative trial of carbenicillin and ampicillin therapy for purulent meningitisTreatment of osteomyelitis and septic arthritis with cefazolin.Pharmacokinetics of cephradine suspension infants and children.Clinicopharmacological evaluation of amoxicillin and probenecid against bacterial meningitis.A validated ultra-performance liquid chromatography-tandem mass spectrometry method for the quantification of polymyxin B in mouse serum and epithelial lining fluid: application to pharmacokinetic studies
P2860
Q30311321-BE27AFFA-BAED-4102-8FC4-5DA8A0993BA5Q33400567-AEB61F10-5F87-4997-A671-CBC3F97DE476Q33689451-63DD7774-9576-462F-BC2B-CE380A763EF0Q33699541-A310542C-5868-48B1-8769-CDF685D6906CQ33727283-8A11A01C-C99F-4ED5-BC89-54E39E44324BQ33727495-0C8C0A4D-843E-4DDC-80A9-10F8423D4328Q33748466-F767867A-3BE1-474B-AFF8-FF77B70AADA6Q33976683-B430F5CA-2985-45C8-86AE-A8D96CC71270Q33983338-80871BFA-FE13-4038-9EBC-15C9376C3C8AQ34057612-AB6BAFA8-3820-412B-BB07-BBB24C9148EAQ34371891-C12616E9-6599-44A9-A6A6-D495F5F33576Q34412153-17E35218-96D6-4113-9CFF-51B6A45DE601Q34517390-748F974E-CD0B-4444-9AE1-DE898A94B7F6Q34720054-D90EB526-52A5-4A0C-AF3A-13604D472E9EQ34906675-1B88C114-0F91-4BBB-BC54-1CB029CDC745Q35004978-F216F80B-837A-4A51-9EA6-13B30DBD511EQ35116133-2BA90360-2527-4E1D-9A0D-34FBCFC6B710Q35118043-E02A337B-EA15-458D-83B0-D9658E736FB1Q35124263-C57E5B7C-3EC9-466E-A289-C68D05A51B05Q35136776-E86F55EF-FFF4-4316-9005-159839514855Q35150278-0B19C1BE-7399-4D43-A8AA-5E142A1E72C0Q35199276-DF0BCB85-F1D5-4CE8-9AC0-5D9DE187F6AAQ35543747-9A002A00-4EBD-4AAC-958C-7DF1505B2006Q35562871-4F216AC5-C62F-426A-BC65-DF8452FF1B2CQ35566354-A9742361-318A-4012-B4B2-7CAEA359A084Q35643461-50357F71-904F-4D78-82F4-A6D057AB7487Q35670787-246EAC10-052D-4A07-AE0E-879733139F8CQ35674507-244E3E66-6102-4BE4-9797-7A73F613A2E7Q35676060-79751591-10B3-4521-B0D3-020738CF452EQ35718258-06B16F7B-6C23-4901-B375-2F2F4E0AA0C4Q35761827-C52D4093-6097-4DB8-BDB8-61A8A70E332EQ35767280-A76BC6EC-0F4C-4027-BAEB-50CDEE8A79B4Q35817800-17FA547B-50B6-4E32-B1A4-988769A2B508Q35821585-7463FCCD-A57F-4EDD-B7F6-79376AA10290Q35822889-EA3C5787-4C20-451C-AFB9-372669613078Q36460522-BAF28CC1-401C-4069-983F-0787547B429AQ36467536-20481EB3-AB7B-4640-B3A3-A877340E69A1Q36481697-38176FB3-DF36-4011-9368-7046D4EDAF1DQ36483851-7B294041-298C-4B24-8270-DF2C7007E14FQ36762991-BCCCC0DF-B99A-4DB4-9C6B-D86C2A4A0690
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1970
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Microbioassay of antimicrobial agents
@en
Microbioassay of antimicrobial agents.
@nl
type
label
Microbioassay of antimicrobial agents
@en
Microbioassay of antimicrobial agents.
@nl
prefLabel
Microbioassay of antimicrobial agents
@en
Microbioassay of antimicrobial agents.
@nl
P1433
P1476
Microbioassay of antimicrobial agents
@en
P304
P577
1970-04-01T00:00:00Z